Placeholder slot
(teh-POH-tih-nib HY-droh-KLOR-ide)
This page contains brief information about tepotinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Tepmetko
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Tepotinib hydrochloride is approved to treat:
- Non-small cell lung cancer that has an abnormal MET gene. It is used in adults whose cancer has spread to other parts of the body.
Tepotinib hydrochloride is also being studied in the treatment of other types of cancer.
More About Tepotinib Hydrochloride
Definition from the NCI Drug Dictionary – Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Targeted Therapy to Treat Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Tepotinib Hydrochloride – Check for trials from NCI’s list of cancer clinical trials now accepting patients.
